Cantex Pharmaceuticals
Weston, US
Cantex Pharmaceuticals is a pharmaceutical company. The website is currently under construction, so no details about its products or focus are available.
Biotech
Founders & leadership
CB
Claude BertrandNamed on SEC filing
SG
Stephen G. MarcusNamed on SEC filing
NF
Neil FlanzraichNamed on SEC filing
CA
Christopher A. KroegerNamed on SEC filing
TC
Todd C. BradyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 1 round · 2013
▶$3.3MraisedApr 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedApr 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Claude BertrandExecutive Officer
- Stephen G. MarcusExecutive Officer, Director
- Neil FlanzraichExecutive Officer, Director
- Christopher A. KroegerDirector
- Todd C. BradyDirector
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Feb 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cantex Pharmaceuticals do?
- Cantex Pharmaceuticals is a pharmaceutical company. The website is currently under construction, so no details about its products or focus are available.
- How much funding has Cantex Pharmaceuticals raised?
- Cantex Pharmaceuticals has disclosed $3.3M raised across 1 round.
- Where is Cantex Pharmaceuticals headquartered?
- Cantex Pharmaceuticals is headquartered in Weston, US.